*杂质对照品
*杂质对照品
*杂质对照品
*杂质对照品

*杂质对照品

参考价: 面议

具体成交价以合同协议为准
2022-06-04 20:50:03
18
产品属性
关闭
深圳远扬化学技术有限公司

深圳远扬化学技术有限公司

初级会员1
收藏

组合推荐相似产品

产品简介

*杂质对照品
提供NMR,HPLC,MS图谱及COA证书,新药申报可用
Ticagrelor Impurity
全部杂质现货供应,*,并可接受定制。

详细介绍

*杂质对照品   产品介绍:
规格:10mg/25mg/50mg/100mg等多种规格可选。
用途:实验研发,药品申报检测,不得用于临床医学诊断。
随货提供:所有杂质对照品均随货提供HPLCNMR,MS图谱及CoA证书。

 

国产进口品牌皆有销售,产品库时常会有更新,另外,我司有专业研发团队,可提供部分杂质定制服务,以zui大可能的满足您杂质对照品的选购需求。

 

*杂质对照品    杂质列表:

Ticagrelor(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 1(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 2(1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 3(1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 4(Mixture of Diastereomers)(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 5(Mixture of Diastereomers)(1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 62-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
Ticagrelor Impurity 7(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 8(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 92-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 105-amino-6-chloro-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 112-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 12(1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 135-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 14(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 15(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 162-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 17(1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 18(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 19(1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 20(1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol
Ticagrelor Impurity 21(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 22(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 23sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate
Ticagrelor Impurity 24(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 25(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 262-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 27(1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 287-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
Ticagrelor Impurity 29(1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol
Ticagrelor Impurity 302-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

 

   除自主杂质对照品品牌外,我司优势代理多个进口杂质品牌:EP,USP,JP,LGC,TRC,TLC,Molcan等,*满足您对杂质对照品的需求。另代理意大利Chromogenix肝素检测试剂,英国NIBSC标准试剂,Sigma-Aldrich试剂, 美国ChromaDex中草药标准品,瑞士CaroteNature类胡萝卜素标准品,法国Extrasynthese中草药标准品,WHO世界卫生组织药物标准品,NIST美国标准局标准品,IRRM欧洲标准局标准品等各种标准品,CIL美国剑桥同位素标准品,种类齐全,到货迅速。

 

     英国NIBSC标准品部分产品列表:

10/175               Reteplase Reference Material

13/322               Polio Anti Sabin type 105 (inactivated) Serum

95/596               Interleukin-57 (Human, rDNA derived)

01/509               Meningococcal serogroup W polysaccharide

13/239               Polio Anti Sabin type 22 (inactivated) Serum

07/300               BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent)

13/249               C-Peptide, Human. 104st International Standard.

95/571               Interleukin-32 (Human, rDNA derived)

95/602               Interleukin-63 (Human, rDNA derived)

10/173               Reteplase Reference Material

10/127               Reteplase Reference Material

01/461               Meningococcal serogroup W polysaccharide

13/294               Polio Anti Sabin type 77 (inactivated) Serum

13/233               C-Peptide, Human. 88st International Standard.

95/572               Interleukin-33 (Human, rDNA derived)

03/104-079         HTLV-64 (antibody) Monitor Sample

13/144               Influenza Antigen B/Massachusetts/02/2022 (Egg derived)

13/180               Influenza Antigen B/Massachusetts/02/2058 (Egg derived)

01/528               Meningococcal serogroup W polysaccharide

13/178               C-Peptide, Human. 33st International Standard.

07/373               BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent)

07/324               BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent)

13/241               C-Peptide, Human. 96st International Standard.

07/290               BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent)

03/104-061         HTLV-46 (antibody) Monitor Sample

07/358               BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)

10/185               Reteplase Reference Material

07/364               BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)

03/104-056         HTLV-41 (antibody) Monitor Sample

13/146               C-Peptide, Human. 1st International Standard.

12/B623-083       QCRFLUAH1N1QC1-Influenza AH1N1 QC81

10/158               Reteplase Reference Material

13/229               C-Peptide, Human. 84st International Standard.

01/428               Meningococcal serogroup W polysaccharide

01/449               Meningococcal serogroup W polysaccharide

13/236               Influenza Antigen B/Massachusetts/02/2114 (Egg derived)

13/233               Influenza Antigen B/Massachusetts/02/2111 (Egg derived)

07/359               BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent)

 

更多关于    的产品信息,请我司。

上一篇:Boc-D-*盐酸盐说明书 下一篇:煤飞灰中重金属成分分析标准物质的样品制备方法
提示

请选择您要拨打的电话:

30073 [{"ID":"684970","CompanyID":"137183","Title":"Boc-D-*盐酸盐说明书","Picture":"","PictureDomain":"","UpdateTime":"2023/11/26 7:05:46","CreateTime":"2023/11/26 7:05:46","ClassName":"技术交流","rn":"3"},{"ID":"672469","CompanyID":"102942","Title":"煤飞灰中重金属成分分析标准物质的样品制备方法","Picture":"","PictureDomain":"","UpdateTime":"2023/10/27 7:46:26","CreateTime":"2023/10/27 7:46:26","ClassName":"技术交流","rn":"4"}]